论文信息 - Anti-CD19 CAR-T Therapy Bridging to Allo-HSCT for Relapsed/refractory B-cell Acute Lymphoblastic Leukemia: An Open-Label Pragmatic Clinical Trial. - 字舞流文

Anti-CD19 CAR-T Therapy Bridging to Allo-HSCT for Relapsed/refractory B-cell Acute Lymphoblastic Leukemia: An Open-Label Pragmatic Clinical Trial.

T. Guo | Huafang Wang | P. Yin | W. Shi | Yu Hu | L. Ai | H. Mei | L. Xia | F. Zhou | R. Jin | Q. Wei | Huiwen Jiang | Jun Deng | Lin Liu | Yaohui Wu | Xuan Lu | Cheng-gong Li | Lu Tang | J. Dong | J. Deng | W. Xiong